Paul Johnson, MD
Undersea and Hyperbaric Medicine · Daytona Beach, FLNPI 1780767616
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,557 of the $2,140 with a category attached, or 72.8%. Biotissue Holdings Inc. accounts for 86.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $1,709 and has fallen 89.6% since, to $178 in 2024.
Across 19 payments — averaging $112.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$2K
- Hydrofera LLC$62
- Next Science LLC$44
- Smith+Nephew$44
- Averitas Pharma Inc.$32
- Kerecis Limited$26
- plus $91 from 5 others
What the payments were for
- Travel & lodging$1,55773%
- Food & beverage$58227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 5 | $1,842 |
| Hydrofera LLC | 2 | $62 |
| Next Science LLC | 2 | $44 |
| Smith+Nephew | 2 | $44 |
| Averitas Pharma Inc. | 1 | $32 |
| Kerecis Limited | 2 | $26 |
| Mimedx Group, Inc. | 1 | $23 |
| Biogen | 1 | $21 |
| Novo Nordisk | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| OVIK Health, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,140 in reported general payments places this provider in the 75th percentile of 32 undersea and hyperbaric medicine providers in Florida.
See all undersea and hyperbaric medicine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 22 | $248 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Daytona Beach
- Stephen PappachenLakeland$1.3M
- Juan BravoLakeland$6K
- Magaly RodriguezTampa$6K
- Lawrence BachlePunta Gorda$4K
- Edgar RhodesJacksonville$3K
- Walter ConlanOrlando$3K
- Paolina PantchevaKissimmee$2K
- Blane ShatkinPembroke Pines$2K
- Reynald AllamClearwater$2K
- Matthew EllisGainesville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.